Some of the names on the move ahead of the open.» Read More
Cramer makes the call on viewers' favorite stocks.
CNBC's David Faber reports on the agreement between Express Scripts and Walgreen, and weighs in on Verizon's earnings.
The "Squawk on the Street" news crew weighs in on a new pharmacy network agreement reached between Express Script and Walgreen. Stock in both companies jumped higher on the announcement.
Arthur Hogan, MD & Head of Product Strategy at Lazard Capital Markets thinks the euro zone will eventually get more good news than bad news. He adds the risk right now is to be positioned against that eventuality.
CNBC's David Faber reports Walgreens comparable sales are down 5.8% from a year ago.
David Kostin, chief U.S. equity strategist at Goldman Sachs, weighs in on which stocks he thinks matter the most, including Apple, Google and Microsoft.
CNBC's Brian Shactman reports under the radar stocks investors should keep an eye on.
CNBC's Herb Greenberg has the story on a big battle brewing over where prescriptions are filled and how much you are going to pay, with Mark Merritt, PCMA president & CEO, and David Balto, antitrust attorney.
The Fast Money traders have the play on Limited Brands.
Deborah Weinswig, Citi analyst, defends her downgrade of WAG, on the heels of its big fight with Express Scripts, with the Fast Money traders.
Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health are growing, with CNBC's Bertha Coombs.
CNBC's David Faber reports on the battle between Walgreens and pharmacy benefit manager, Express Scripts.